SITAGLIPTIN PHOSPHATE 100mg. IP

A dipeptidyl peptidase IV inhibitor that controls high blood sugar and is used in the management of type 2 diabetes mellitus. (Shannon Miller, 2006) A potential agent that decreases insulin resistance in type 2 diabetes patients. (Tuan Dinh Le N. T., 2020) An effective and generally well-tolerated treatment option for the management of patients with type 2 diabetes. (Plosker, 2014) Improves fasting and postprandial glycemic control without hypoglycemia or weight gain in patients with type 2 diabetes. (G A Herman, 2007) Provides effective fasting and postprandial glycemic control in a wide range of patients with type 2 diabetes. (Avraham Karasik, 2008) A potent therapeutic drug that improves insulin secretion from pancreatic beta cells, restores glycemic control, and prevents beta cell destruction. (H van Bronswijk, 2008)